• Home
  • Business
  • General
  • Health
  • Lifestyle
  • Marketing
  • Real Estate
  • Technology
  • Travel
Our Latest Posts

The Next 7 Things You Should Do For Winbet Club Success

September 16, 2023

List of Best Live Dealer Baccarat US Online Casinos

September 16, 2023

The Basics of Crypto Recovery

September 5, 2023

7 Ways To Invest In Sports Betting Stocks And Funds

August 30, 2023
Facebook Twitter Instagram WhatsApp
Facebook Twitter Instagram WhatsApp
News DeeperNews Deeper
Login
  • Home
  • Business

    Why Online Reviews are Important for Customers And Businesses

    July 30, 2023

    7 Websites That Will Pay You Daily Easy Work From Home Jobs

    July 23, 2023

    Credit Card Cash: Unlocking the Power of Instant Funds

    July 16, 2023

    Cheonan Business Trip Massage Guide

    June 28, 2023

    Personal Loans For the Unemployed

    June 27, 2023
  • General

    How to Tell If a Website is Legit in 6 Easy Steps

    July 27, 2023

    What Everyone Ought to Know About Buy Cheap RU58841

    May 14, 2023

    The Hair Relaxer Cancer Lawsuit: Understanding the Legal Rights of Consumers

    April 5, 2023

    Protect Your Assets and Loved Ones with the Help of a Trusted Honolulu Attorney

    March 21, 2023

    Best Fake ID Websites: What A Mistake!

    February 25, 2023
  • Health

    Otitis Media: How to Manage an Ear Infection

    June 15, 2023

    Discover Best Smile With Jacksonville FL’s Top-Rated Dentists

    April 2, 2023

    Effective Marketing Strategies for Home Care Services

    September 29, 2022

    Boost Testosterone – 4 X Proven Herbs For Naturally Boosting Testosterone!

    September 24, 2022

    Education And Certification For Medical Assistants

    August 25, 2022
  • Lifestyle

    Hospice Los Angeles County Offers Physical, Emotional And Spiritual Support.

    February 19, 2023

    What Is A Dakimakura?

    February 8, 2023

    Buy A Body Pillow

    December 28, 2022

    Creating a Lifestyle Blog For Blogging

    December 15, 2022

    Top 5 Tattoos Designs You Should Know

    December 13, 2022
  • Marketing

    Site That Allows You To Download Your Favorite Ringtone

    August 29, 2022

    How should I write my blog posts? Detailed guide

    August 29, 2022

    Get the Benefits By Purchasing the Email Lists For Marketing

    July 21, 2022

    CDMO Samsung Biologics CEO Outlines “Multidimensional Growth Plan” at 11th Annual Shareholders Meeting

    May 18, 2022

    Dealing With Multiple Job Offers? How to Decide Between Two Jobs

    April 9, 2022
  • Real Estate

    4 Motives to Invest in Belizean Real Estate

    May 20, 2023

    How to Stay Safe as a Construction Worker

    June 23, 2022

    How to Transfer Your Data to Property Management Software

    May 31, 2022

    Bridge Types: Tensile & Compressive Forces

    May 18, 2022

    Property Marketing Plan

    May 16, 2022
  • Technology

    How Many Types of VPS Are There? What Are the Different Types of VPS Hosting Available?

    March 22, 2023

    Affordable Refrigerator Filters for Improved Water and Ice Quality

    March 20, 2023

    What Can You Expect to Learn from Mechanical Engineering Design Courses?

    December 27, 2022

    The different types of managed it services

    August 6, 2022

    What Do Electric Vehicle Charging Stations Do With Diversity, Equity, and Inclusion?

    July 25, 2022
  • Travel

    Taipei Self-Driving Gharry Review

    June 5, 2023

    Taiwan Self-Driving Gharry

    June 5, 2023

    Why You Choose Niagara Falls Party Bus Rental?

    December 24, 2022

    Offer More Details on Kayak Fishing

    August 31, 2022

    The Endless Benefits of Outdoor Activities for Beating Addiction

    May 10, 2022
News DeeperNews Deeper
Home»Marketing»CDMO Samsung Biologics CEO Outlines “Multidimensional Growth Plan” at 11th Annual Shareholders Meeting
Marketing

CDMO Samsung Biologics CEO Outlines “Multidimensional Growth Plan” at 11th Annual Shareholders Meeting

John EshanBy John EshanMay 18, 2022Updated:May 23, 2022No Comments5 Mins Read
Facebook Twitter Pinterest LinkedIn WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest Email

Samsung Biologics, a leading contract development and manufacturing organization (CDMO), held its 11th Annual General Meeting of Shareholders (AGM) on March 28, 2022. At the meeting, Samsung Biologics CEO John Rim summarized the company’s growth in 2021 and outlined a “multidimensional growth plan” for future development across the company’s three core pillars: increasing CDMO capacity, enhancing portfolio diversification, and expanding its global footprint.

A Productive 2021

In a letter to shareholders, Rim recapped Samsung Biologics’ key activities and milestones from 2021 and discussed how these fit into the CDMO’s ambitious plans for future growth.

Samsung Biologics played an important role in the global supply of COVID-19 vaccines in 2021, utilizing its substantial manufacturing capacity to partner with Moderna to fill/finish mRNA COVID-19 vaccines.

“Samsung Biologics was the first in Korea to perform fill/finish manufacturing of Moderna’s COVID-19 mRNA vaccine and obtain approval from the Korean Ministry of Food and Drug Safety. Samsung Biologics will continue to dedicate itself to providing a reliable supply of COVID-19 vaccines and treatments and contribute to the ending of the prolonged COVID-19 global pandemic,” said Rim.

As a CDMO, Samsung Biologics has both drug development and manufacturing operations. While its role in mRNA vaccine production in 2021 was on the manufacturing side, the company also made advancements in its drug development capabilities, launching the S-Cellerate™ drug development platform.

Rim explained that S-Cellerate™ was designed to “offer clients an integrated and seamless drug development solution resulting in accelerated timelines, improving both economics and convenience.”

Fueled by increasing CDMO demand during the COVID-19 pandemic, Samsung Biologics experienced significant profit growth in 2021, reporting a revenue increase of 35%. The company also increased its employment rate by 37% in 2021, keeping pace with its annual employment increase rate of 43% since its establishment in 2011.

This growth comes as Samsung Biologics took several steps to commit to sustainable development in 2021. It released its first-ever sustainability report and developed an enhanced Environmental, Social, and Governance (ESG) management system, which included the establishment of an ESG Committee. In addition, Samsung Biologics was recognized with an “A” ESG rating from the Korea Corporate Governance Services and became the first Korean pharmaceutical company to be added to the Dow Jones Sustainability World Index.

Multidimensional Growth

Samsung Biologics’ 2021 has set the stage for what Rim called a “multidimensional growth plan.” Several plans for future growth were outlined in Rim’s letters to shareholders. The plans were divided into three categories:

1.)   CDMO Capacity

Samsung Biologics currently operates three large plants in Songdo, South Korea, and its Plant 4 is now under construction, with plans to start partial operations in Q4 2022 and operate at full capacity by mid-2023, six months ahead of the original schedule. With an expected capacity of 256,000 liters, Plant 4 will be the largest CDMO facility in the world, and it will bring Samsung Biologics’ expected total manufacturing capacity to 620,000 liters.

The company is currently in the process of planning manufacturing activities for the plant.

“We have already secured CMO contracts for five different products with three global companies for Plant 4 as a result of steady pre-sales activities,” said Rim.

In addition to Plant 4, Rim noted Samsung Biologics’ plans to purchase land for the construction of a Bio Campus II facility in 2022. Rim explained that the facility is expected to have a landmass 30% greater than the company’s current Bio Campus I facility in Songdo. It will serve as the site for construction of future large-scale plants and an Open Innovation Center.

2.)   Portfolio

While it continues to develop its primary business as an antibody CDMO, Samsung Biologics is actively expanding its portfolio and capabilities.

The company recently acquired full ownership of Bioepis, which was started as a joint venture with Biogen in 2012. With the acquisition, Samsung Biologics plans to strengthen its capabilities in the development of biosimilars, which offer cost-effective alternatives to biologic reference medicines. Bioepis has successfully launched five biosimilars globally, in addition to one recently approved biosimilar and four currently in Phase 3 clinical trials. The company has focused on immunology and oncology applications and is expanding into ophthalmology, hematology, gastroenterology, and endocrinology.

““Today’s announcement marks a significant milestone for Samsung Biologics in our continued venture into the biosimilar business and accelerating biosimilar growth. By leveraging our extensive experience as a leading CDMO, we will further contribute to saving lives of the patients and address a wide array of diseases,” said Rim.

Samsung Biologics is also expanding its mRNA vaccine production capabilities, adding drug substance manufacturing to its drug product manufacturing capabilities. Rim explained that the company is adding an mRNA drug substance manufacturing facility, expected to be ready for current Good Manufacturing Practices operations within the first half of 2022. The facility will offer end-to-end manufacturing for mRNA vaccines and therapeutics and is scheduled to begin manufacturing GreenLight Biosciences’ mRNA COVID-19 vaccine candidate.

 3.)   Geography

Samsung Biologics continues to expand at its headquarters in South Korea, and it’s also exploring options to establish more operations worldwide. This process began when Samsung Biologics launched a research and development center in the San Francisco biotech cluster in 2020, and the CDMO is currently exploring options to launch additional facilities in the U.S. and Europe in an effort to meet increasing global demand for its services.

Building a Better Future

Ultimately, Rim emphasized that Samsung Biologics’ growth will benefit patients as the biopharma industry continues to innovate in both development and manufacturing capabilities.

“As a leading CDMO service provider, we will continue to demonstrate our excellent business operations throughout our value chains to ultimately contribute to saving the lives of patients and build a better future for all,” said Rim.

CEO
Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
Previous ArticleBridge Types: Tensile & Compressive Forces
Next Article Wash Your Car With An Eco-Friendly And Sustainable Car Cleaning
John Eshan

Related Posts

Site That Allows You To Download Your Favorite Ringtone

August 29, 2022By John Eshan

How should I write my blog posts? Detailed guide

August 29, 2022By John Eshan

Get the Benefits By Purchasing the Email Lists For Marketing

July 21, 2022By William Smith

Dealing With Multiple Job Offers? How to Decide Between Two Jobs

April 9, 2022By John Eshan

Leave A Reply Cancel Reply

Categories
  • Automotive (15)
  • Beauty (12)
  • Business (75)
  • Digital Marketing (15)
  • Education (14)
  • Entertainment (13)
  • Fitness (5)
  • Forex & Crypto (1)
  • General (66)
  • Health (24)
  • Houses (50)
  • Lifestyle (24)
  • Marketing (9)
  • Parenting (2)
  • Pets (4)
  • Real Estate (11)
  • Safety and Security (11)
  • Social Media (5)
  • Sports (55)
  • Technology (41)
  • Travel (12)
Our Latest Posts

The Next 7 Things You Should Do For Winbet Club Success

September 16, 2023

List of Best Live Dealer Baccarat US Online Casinos

September 16, 2023

The Basics of Crypto Recovery

September 5, 2023

7 Ways To Invest In Sports Betting Stocks And Funds

August 30, 2023

Buy GMB Reviews: How to Improve Your Online Reputation

August 5, 2023
Facebook Twitter Instagram WhatsApp
  • About Us
  • Privacy Policy
  • Betflix
  • Contact Us
Copyright © 2023 NewsDeeper | All Rights Reserved

Type above and press Enter to search. Press Esc to cancel.

Sign In or Register

Welcome Back!

Login to your account below.

Lost password?